restor3d Sets November Commercial Rollout for Velora 3D-Printed Hip Cup-3DPTimes

Home > Applications

restor3d Sets November Commercial Rollout for Velora 3D-Printed Hip Cup

November 5, 2026 Applications 3DPTimes Editors | restor3d and U.S. FDA 10 Share to X.com

The November 2 update puts Velora on a full commercial rollout this month, reports initial Identity KA knee cases and sets a 2027 target for the Identity 3DP Porous knee system.

Research archive, 2020. Two retrieved 3D-printed acetabular cups from a separate study, shown as examples of porous hip implant surfaces. Dall’Ava et al., Figure 7, CC BY 4.0, unchanged. https://doi.org/10.1186/s13018-020-01665-y

What the printed hip cup changes

restor3d announced on November 2, 2026 that its Velora Acetabular System is moving from limited availability to full commercial release in November. The company plans to showcase the system at the American Association of Hip and Knee Surgeons annual meeting. Velora is an off-the-shelf hip system. Its 3D-printed titanium cup has an interconnected porous surface designed to allow bone to grow into it.

The company says a 48 mm cup can accept a 36 mm femoral head and a 52 mm cup can accept a 40 mm head, depending on the compatible liner. Its cup range spans 40–70 mm. The engineering challenge is to preserve room for the liner and head inside the shell while maintaining the fit and strength of the cup. The FDA’s 510(k) summary lists bench evaluations for shell fatigue and deformation, liner locking and impingement, and range of motion. The November update did not report comparative patient outcomes.

Cover photo. Two 3D-printed acetabular cups recovered for a separate research study, shown for context. Dall’Ava et al. (2020), Figure 7, unchanged. https://doi.org/10.1186/s13018-020-01665-y | https://creativecommons.org/licenses/by/4.0/

Image below. Photographs and scanning electron micrographs compare the porous surface of a 3D-printed acetabular cup with a conventional beaded surface. These are research specimens from the same independent study. Dall’Ava et al. (2020), Figure 3, unchanged. https://doi.org/10.1186/s13018-020-01665-y | https://creativecommons.org/licenses/by/4.0/

The two knee programs are at different stages

The company also reported completing its first limited-release cases with Identity Kinematic Alignment. That planning option adds the patient’s native leg alignment to an existing workflow that uses CT scans to design the femoral component. The early cases mark the start of real-world use in the limited release.

Separately, restor3d is targeting full commercial release of the Identity 3DP Porous knee system in 2027. It pairs a printed cobalt-chromium femoral component with a titanium tibial baseplate. The FDA issued a 510(k) substantial-equivalence determination for the cruciate-retaining Identity 3DP Porous system in March 2025. The commercial target therefore refers to broader availability.

Sources
restor3d announcement via Business Wire, November 2, 2026
https://www.businesswire.com/news/home/20261102974937/en/
U.S. FDA, Velora Acetabular System 510(k) summary, December 5, 2025
https://www.accessdata.fda.gov/cdrh_docs/pdf25/K252067.pdf
U.S. FDA, Identity 3DP Porous clearance record, March 27, 2025
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K243768